中国医药
中國醫藥
중국의약
CHINA MEDICINE
2010年
2期
123-124
,共2页
胰胆道疾病%胰胆管造影%高龄患者
胰膽道疾病%胰膽管造影%高齡患者
이담도질병%이담관조영%고령환자
Biliary and pancreatic disease%Endoscopic retrograde cholangiopancreatography%Ad-vanced age
目的 评估≥80岁高龄患者应用逆行性胰胆管造影(ERCP)的有效性和安全性.方法 对53例患者进行积极的术前准备,合并有心肺等疾病的患者予以有效的治疗.根据ERCP检查结果制订治疗方案.结果 92.45%(49/53)实施了治疗性ERCP.其中36例胆总管结石患者接受了乳头括约肌切开(EST)并成功取出结石,行鼻胆引流管置入(ENBD)术42例,内支架置入术7例.并发症发生率9.43%(5/53),无严重并发症及死亡发生.结论 治疗性ERCP对≥80岁高龄患者是安全和有效的,高龄不应成为限制该项技术应用的禁忌.
目的 評估≥80歲高齡患者應用逆行性胰膽管造影(ERCP)的有效性和安全性.方法 對53例患者進行積極的術前準備,閤併有心肺等疾病的患者予以有效的治療.根據ERCP檢查結果製訂治療方案.結果 92.45%(49/53)實施瞭治療性ERCP.其中36例膽總管結石患者接受瞭乳頭括約肌切開(EST)併成功取齣結石,行鼻膽引流管置入(ENBD)術42例,內支架置入術7例.併髮癥髮生率9.43%(5/53),無嚴重併髮癥及死亡髮生.結論 治療性ERCP對≥80歲高齡患者是安全和有效的,高齡不應成為限製該項技術應用的禁忌.
목적 평고≥80세고령환자응용역행성이담관조영(ERCP)적유효성화안전성.방법 대53례환자진행적겁적술전준비,합병유심폐등질병적환자여이유효적치료.근거ERCP검사결과제정치료방안.결과 92.45%(49/53)실시료치료성ERCP.기중36례담총관결석환자접수료유두괄약기절개(EST)병성공취출결석,행비담인류관치입(ENBD)술42례,내지가치입술7례.병발증발생솔9.43%(5/53),무엄중병발증급사망발생.결론 치료성ERCP대≥80세고령환자시안전화유효적,고령불응성위한제해항기술응용적금기.
Objective To evaluate the efficacy and the safety of therapeutic endoscopic retrograde cholan-giopancreatography(ERCP) in octogenrian, Methods Complete preparation should be carried out before procedure. The circulative and respiratory diseases should be treated effectively. The treatment was determined according to pa-tient's condition after ERCP. Results Therapeutic ERCP were done in 49/53 (92.45%), 36 common bile duct stones patients underwent endoscopic sphincterotomy (EST). 42 endoscopic nasobiliary drainage (ENBD) were done. Stents were used in 7 cancer patients. Complications were observed in 9.43% (5/53) of therapeutic ERCP but no severe complications and death occured. Conclusion Therapeutic ERCP is safe and effective for the treatment of pancreatobiliary diseases in octogenrian.
